These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2729754)

  • 1. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS; Kreiss K; King TE; Seay S; Campbell PA
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pulmonary physiologic abnormalities in beryllium disease.
    Pappas GP; Newman LS
    Am Rev Respir Dis; 1993 Sep; 148(3):661-6. PubMed ID: 8368637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum angiotensin converting enzyme activity in chronic beryllium disease.
    Newman LS; Orton R; Kreiss K
    Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening blood test identifies subclinical beryllium disease.
    Kreiss K; Newman LS; Mroz MM; Campbell PA
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
    Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
    Huang H; Meyer KC; Kubai L; Auerbach R
    Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable response to long-term corticosteroid therapy in chronic beryllium disease.
    Sood A; Beckett WS; Cullen MR
    Chest; 2004 Dec; 126(6):2000-7. PubMed ID: 15596705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term response to corticosteroid therapy in chronic beryllium disease.
    Marchand-Adam S; El Khatib A; Guillon F; Brauner MW; Lamberto C; Lepage V; Naccache JM; Valeyre D
    Eur Respir J; 2008 Sep; 32(3):687-93. PubMed ID: 18757698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.
    Inoue Y; Barker E; Daniloff E; Kohno N; Hiwada K; Newman LS
    Am J Respir Crit Care Med; 1997 Jul; 156(1):109-15. PubMed ID: 9230733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.